Citations (90)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Aurora K. Authement & Nina Isoherranen. (2024) The impact of pregnancy and associated hormones on the pharmacokinetics of Δ9-tetrahydrocannabinol. Expert Opinion on Drug Metabolism & Toxicology 20:1-2, pages 73-93.
Read now
Read now
Luca Boscolo Bielo, Stefano Natangelo, Jalissa Katrini, Dario Trapani & Giuseppe Curigliano. (2023) A comprehensive update of hormone-related pharmacokinetic variations associated with breast cancer drugs. Expert Opinion on Drug Metabolism & Toxicology 19:7, pages 389-403.
Read now
Read now
Ian R. Mulrenin, Julian E. Garcia, Muluneh M. Fashe, Matthew Shane Loop, Melissa A. Daubert, Rachel Peragallo Urrutia & Craig R. Lee. (2021) The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions. Expert Opinion on Drug Metabolism & Toxicology 17:11, pages 1261-1279.
Read now
Read now
Megan Neary, Andrew Owen & Adeniyi Olagunju. (2020) Pharmacokinetics of HIV therapies in pregnant patients: an update. Expert Opinion on Drug Metabolism & Toxicology 16:6, pages 449-461.
Read now
Read now
Laura A Magee, Shirin Namouz-Haddad, Vivien Cao, Gideon Koren & Peter von Dadelszen. (2015) Labetalol for hypertension in pregnancy. Expert Opinion on Drug Safety 14:3, pages 453-461.
Read now
Read now
Anders Helldén & Parvaz Madadi. (2013) Pregnancy and Pharmacogenomics in the Context of Drug Metabolism and Response. Pharmacogenomics 14:14, pages 1779-1791.
Read now
Read now
Satya Prakash Tripathi, Anuseema Bhadauriya, Abhijeet Patil & Abhay T. Sangamwar. (2013) Substrate selectivity of human intestinal UDP-glucuronosyltransferases (UGTs): in silico and in vitro insights. Drug Metabolism Reviews 45:2, pages 231-252.
Read now
Read now
Michael W. Sinz. (2013) Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development. Drug Metabolism Reviews 45:1, pages 3-14.
Read now
Read now
Hyunyoung Jeong. (2010) Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes. Expert Opinion on Drug Metabolism & Toxicology 6:6, pages 689-699.
Read now
Read now
Articles from other publishers (81)
A. L. Chernyshova, V. A. Markovich, A. A. Chernyakov, S. E. Krasilnikov, A. O. Shumeikina, Yu. M. Trushuk, O. S. Dil, A. E. Chernyshova & Ya. I. Arkhipova. (2024) Colorectal cancer and pregnancy. Koloproktologia 23:1, pages 100-107.
Crossref
Crossref
Priyanaka Devi & Prasann Kumar. 2023. Herbal Medicine Phytochemistry. Herbal Medicine Phytochemistry
1
31
.
Lauren A. Borda, Mats Någård, David W. Boulton, Raman Venkataramanan & Paola Coppola. (2023) A systematic review of pregnancy-related clinical intervention of drug regimens due to pharmacokinetic reasons. Frontiers in Medicine 10.
Crossref
Crossref
John O. Miners, Thomas M. Polasek, Julie-Ann Hulin, Andrew Rowland & Robyn Meech. (2023) Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance. Pharmacology & Therapeutics 248, pages 108459.
Crossref
Crossref
Yudi Song, Wei Wang, Xinyang Liu, Jingsi Chen, Dunjin Chen, Xiaoyi Wang, Wei Li & Defang Ouyang. (2023) Physiologically Based Pharmacokinetic Modeling for Multiple Oral Administration Labetalol in Pregnant Women. Pharmaceutical Research 40:7, pages 1765-1775.
Crossref
Crossref
André Dallmann, John van den Anker, Homa K. Ahmadzia & Natella Rakhmanina. (2023) Mechanistic Modeling of the Drug‐Drug Interaction Between Efavirenz and Dolutegravir: Is This Interaction Clinically Relevant When Switching From Efavirenz to Dolutegravir During Pregnancy?. The Journal of Clinical Pharmacology 63:S1.
Crossref
Crossref
Catherine S. Stika. (2023) Principles of Obstetric Pharmacology. Obstetrics and Gynecology Clinics of North America 50:1, pages 1-15.
Crossref
Crossref
Shahzad Kamran, Rukhsana Anwar, Afifa Noor, Muhammad Ihsan Ullah, Alaa A. Bagalagel, Mohammed M. Aldurdunji & Saiqa Ishtiaq. (2023) Metabolic Profiling and Investigation of the Modulatory Effect of Fagonia cretica L. Aerial Parts on Hepatic CYP3A4 and UGT2B7 Enzymes in Streptozotocin—Induced Diabetic Model. Antioxidants 12:1, pages 119.
Crossref
Crossref
Emma G. Foster, Howard E. Gendelman & Aditya N. Bade. (2022) HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment. Pharmaceuticals 15:12, pages 1533.
Crossref
Crossref
Muluneh M. Fashe, John K. Fallon, Taryn A. Miner, Jacqueline B. Tiley, Philip C. Smith & Craig R. Lee. (2022) Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes. Frontiers in Pharmacology 13.
Crossref
Crossref
Matthijs W. van Hoogdalem, Scott L. Wexelblatt, Henry T. Akinbi, Alexander A. Vinks & Tomoyuki Mizuno. (2022) A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome. Pharmacology & Therapeutics 234, pages 108045.
Crossref
Crossref
Nadia M. Ikumi, Dilly Anumba & Mushi Matjila. (2022) Pharmacokinetics and placental transfer of dolutegravir in pregnancy. Journal of Antimicrobial Chemotherapy 77:2, pages 283-289.
Crossref
Crossref
Shaimaa Alsulami, Sultan N. Alotaibi, Nader Damfu, Doaa M. Aljefri, Hadeel Ahmed Altayib & Maher Alharbi. (2022) Efficacy and Safety of Bictegravir-Based Regimen in Pregnant Women Living with HIV: A Case Report. Journal of the International Association of Providers of AIDS Care (JIAPAC) 21, pages 232595822211461.
Crossref
Crossref
Catherine S. Stika & Marilynn C. Frederiksen. 2022. Atkinson's Principles of Clinical Pharmacology. Atkinson's Principles of Clinical Pharmacology
425
454
.
Rachel Ryu & Mary F. Hebert. 2022. Clinical Pharmacology During Pregnancy. Clinical Pharmacology During Pregnancy
19
46
.
Nicolás R. Robles, Francesco Fici, Julian Valladares & Guido Grassi. (2021) Antiretroviral Treatment and Antihypertensive Therapy. Current Pharmaceutical Design 27:40, pages 4116-4124.
Crossref
Crossref
Aminah Almurjan, Hannah Macfarlane & Raj K. S. Badhan. (2021) The application of precision dosing in the use of sertraline throughout pregnancy for poor and ultrarapid metabolizer CYP 2C19 subjects: A virtual clinical trial pharmacokinetics study. Biopharmaceutics & Drug Disposition 42:6, pages 252-262.
Crossref
Crossref
Raju Khatri, John K. Fallon, Craig Sykes, Natasha Kulick, Rebecca J. B. Rementer, Taryn A. Miner, Amanda P. Schauer, Angela D. M. Kashuba, Kim A. Boggess, Kim L. R. Brouwer, Philip C. Smith & Craig R. Lee. (2021) Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes. Frontiers in Pharmacology 12.
Crossref
Crossref
Caroline Sychterz, Aleksandra Galetin & Kunal S. Taskar. (2021) When special populations intersect with drug–drug interactions: Application of physiologically‐based pharmacokinetic modeling in pregnant populations. Biopharmaceutics & Drug Disposition 42:4, pages 160-177.
Crossref
Crossref
Raju Khatri, Natasha Kulick, Rebecca J.B. Rementer, John K. Fallon, Craig Sykes, Amanda P. Schauer, Melina M. Malinen, Merrie Mosedale, Paul B. Watkins, Angela D.M. Kashuba, Kim A. Boggess, Philip C. Smith, Kim L.R. Brouwer & Craig R. Lee. (2021) Pregnancy-Related Hormones Increase Nifedipine Metabolism in Human Hepatocytes by Inducing CYP3A4 Expression. Journal of Pharmaceutical Sciences 110:1, pages 412-421.
Crossref
Crossref
Johana Díaz-Santa, Rocío Rodríguez-Romanos, Gemma Osca, Marta Pratcorona, Ana Garrido, Rosa Coll, Carla Moret, Lourdes Escoda, Mar Tormo, Inma Heras, Montse Arnan, Susanna Vives, Olga Salamero, Natàlia Lloveras, Joan Bargay, Antònia Sampol, David Cruz, Antoni Garcia, Teresa Quiñones, Jordi Esteve, Jorge Sierra & David Gallardo. (2020) UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy. Leukemia 34:11, pages 2925-2933.
Crossref
Crossref
Kimberly K. Scarsi, Joshua P. Havens, Anthony T. Podany, Sean N. Avedissian & Courtney V. Fletcher. (2020) HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety. Drugs 80:16, pages 1649-1676.
Crossref
Crossref
Xiaomei I. Liu, Jeremiah D. Momper, Natella Y. Rakhmanina, Dionna J. Green, Gilbert J. Burckart, Tim R. Cressey, Mark Mirochnick, Brookie M. Best, John N. van den Anker & André Dallmann. (2020) Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling. Clinical Pharmacokinetics 59:11, pages 1433-1450.
Crossref
Crossref
Paulo Vinicius Bernardes Gonçalves, Fernanda de Lima Moreira, Jhohann Richard de Lima Benzi, Ricardo Carvalho Cavalli, Geraldo Duarte & Vera Lucia Lanchote. (2020) Nonrelevant Pharmacokinetic Drug‐Drug Interaction Between Furosemide and Pindolol Enantiomers in Hypertensive Parturient Women. The Journal of Clinical Pharmacology 60:11, pages 1527-1529.
Crossref
Crossref
Vera E. Bukkems, Angela Colbers, Catia Marzolini, Jose Molto & David M. Burger. (2020) Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?. Clinical Pharmacokinetics 59:10, pages 1217-1236.
Crossref
Crossref
Yi Zheng, Déborah Hirt, Sandrine Delmas, Gabrielle Lui, Sihem Benaboud, Jerome Lechedanec, Jean-Marc Tréluyer, Camille Chenevier-Gobeaux, Elisa Arezes, Ambre Gelley, Imane Amri, Saïk Urien, Naïm Bouazza, Frantz Foissac, Josiane Warszawski & Jade Ghosn. (2020) Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial. Antimicrobial Agents and Chemotherapy 64:10.
Crossref
Crossref
Anthony T. Podany, Kimberly K. Scarsi, Michelle M. Pham & Courtney V. Fletcher. (2020) Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors: An Updated Review. Clinical Pharmacokinetics 59:9, pages 1085-1107.
Crossref
Crossref
Jamil M. Kazma, John van den Anker, Karel Allegaert, André Dallmann & Homa K. Ahmadzia. (2020) Anatomical and physiological alterations of pregnancy. Journal of Pharmacokinetics and Pharmacodynamics 47:4, pages 271-285.
Crossref
Crossref
Yuejian Liu, Justine Badée, Ryan H. Takahashi, Stephan Schmidt, Neil Parrott, Stephen Fowler, Peter I. Mackenzie, Michael W. H. Coughtrie & Abby C. Collier. (2019) Coexpression of Human Hepatic Uridine Diphosphate Glucuronosyltransferase Proteins: Implications for Ontogenetic Mechanisms and Isoform Coregulation. The Journal of Clinical Pharmacology 60:6, pages 722-733.
Crossref
Crossref
Jolien J.M. Freriksen, Stein Schalkwijk, Angela P. Colbers, Khaled Abduljalil, Frans G.M. Russel, David M. Burger & Rick Greupink. (2020)
Assessment of Maternal and Fetal Dolutegravir Exposure by Integrating
Ex Vivo
Placental Perfusion Data and Physiologically‐Based Pharmacokinetic Modeling
. Clinical Pharmacology & Therapeutics 107:6, pages 1352-1361.
Crossref
Crossref
Hannah K. Betcher & Alfred L. GeorgeJr.Jr.. (2020) Pharmacogenomics in pregnancy. Seminars in Perinatology 44:3, pages 151222.
Crossref
Crossref
Emily A. Pinheiro & Catherine S. Stika. (2020) Drugs in pregnancy: Pharmacologic and physiologic changes that affect clinical care. Seminars in Perinatology 44:3, pages 151221.
Crossref
Crossref
Pauline Bollen, Jolien Freriksen, Deborah Konopnicki, Katharina Weizsäcker, Carmen Hidalgo Tenorio, José Moltó, Graham Taylor, Irene Alba-Alejandre, Reinout van Crevel, Angela Colbers, David Burger, J Nellen, F Lyons, J Lambert, C Wyen, G Faetkenheuer, J K Rockstroh, C Schwarze-Zander, S Tariq Sadiq, Y Gilleece, C Wood, S Schalkwijk & V Bukkems. (2020) The Effect of Pregnancy on the Pharmacokinetics of Total and Unbound Dolutegravir and Its Main Metabolite in Women Living With Human Immunodeficiency Virus. Clinical Infectious Diseases.
Crossref
Crossref
Sílvia M. Illamola, Ogochukwu U. Amaeze, Lubov V. Krepkova, Angela K. Birnbaum, Ashwin Karanam, Kathleen M. Job, Valentina V. Bortnikova, Catherine M.T. Sherwin & Elena Y. Enioutina. (2020) Use of Herbal Medicine by Pregnant Women: What Physicians Need to Know. Frontiers in Pharmacology 10.
Crossref
Crossref
E.M. Hodel, C. Marzolini, C. Waitt & N. Rakhmanina. (2019) Pharmacokinetics, Placental and Breast Milk Transfer of Antiretroviral Drugs in Pregnant and Lactating Women Living with HIV. Current Pharmaceutical Design 25:5, pages 556-576.
Crossref
Crossref
Ruben van der Galiën, Rob ter Heine, Rick Greupink, Stein J. Schalkwijk, Antonius E. van Herwaarden, Angela Colbers & David M. Burger. (2018) Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps. Clinical Pharmacokinetics 58:3, pages 309-323.
Crossref
Crossref
Takaya Kutsukake, Yoichi Furukawa, Kyoko Ondo, Saki Gotoh, Tatsuki Fukami & Miki Nakajima. (2019) Quantitative Analysis of UDP-Glucuronosyltransferase Ugt1a and Ugt2b mRNA Expression in the Rat Liver and Small Intestine: Sex and Strain Differences. Drug Metabolism and Disposition 47:1, pages 38-44.
Crossref
Crossref
Anna-Katharina Hankele, Stefan Bauersachs & Susanne E. Ulbrich. (2018) Conjugated estrogens in the endometrium during the estrous cycle in pigs. Reproductive Biology 18:4, pages 336-343.
Crossref
Crossref
Shujuan Chen & Robert H. Tukey. (2018)
Humanized
UGT1
Mice, Regulation of
UGT1A1
, and the Role of the Intestinal Tract in Neonatal Hyperbilirubinemia and Breast Milk-Induced Jaundice
. Drug Metabolism and Disposition 46:11, pages 1745-1755.
Crossref
Crossref
Chen Xu, Jie Gao, Hai-Feng Zhang, Na Gao, Yuan-yuan Guo, Yan Fang, Qiang Wen & Hai-Ling Qiao. (2018) Content and Activities of UGT2B7 in Human Liver In Vitro and Predicted In Vivo: A Bottom-Up Approach. Drug Metabolism and Disposition 46:9, pages 1351-1359.
Crossref
Crossref
Jia Yin Soo, Michael D. Wiese, Mary J. Berry & Janna L. Morrison. (2018) Does poor fetal growth influence the extent of fetal exposure to maternal medications?. Pharmacological Research 130, pages 74-84.
Crossref
Crossref
Nikki Mulligan, Brookie M. Best, Jiajia Wang, Edmund V. Capparelli, Alice Stek, Emily Barr, Shelley L. Buschur, Edward P. Acosta, Elizabeth Smith, Nahida Chakhtoura, Sandra Burchett & Mark Mirochnick. (2018) Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV. AIDS 32:6, pages 729-737.
Crossref
Crossref
Michael Z. Liao, Chunying Gao, Brian R. Phillips, Naveen K. Neradugomma, Lyrialle W. Han, Deepak Kumar Bhatt, Bhagwat Prasad, Danny D. Shen & Qingcheng Mao. (2018) Pregnancy Increases Norbuprenorphine Clearance in Mice by Induction of Hepatic Glucuronidation. Drug Metabolism and Disposition 46:2, pages 100-108.
Crossref
Crossref
Catia Marzolini, Laurent Decosterd, Ursula Winterfeld, Frédéric Tissot, Katyuska Francini, Thierry Buclin & Françoise Livio. (2017) Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report. British Journal of Clinical Pharmacology 83:12, pages 2835-2838.
Crossref
Crossref
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
309
329
.
Evelien Van Rymenant, László Abrankó, Sarka Tumova, Charlotte Grootaert, John Van Camp, Gary Williamson & Asimina Kerimi. (2017) Chronic exposure to short-chain fatty acids modulates transport and metabolism of microbiome-derived phenolics in human intestinal cells. The Journal of Nutritional Biochemistry 39, pages 156-168.
Crossref
Crossref
Marianne Garland. 2017. Fetal and Neonatal Physiology. Fetal and Neonatal Physiology
229
238.e1
.
J.E. Moscovitz, L. Gorczyca & L.M. Aleksunes. 2017. Drug Metabolism in Diseases. Drug Metabolism in Diseases
207
240
.
Anthony T. Podany, Kimberly K. Scarsi & Courtney V. Fletcher. (2016) Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors. Clinical Pharmacokinetics 56:1, pages 25-40.
Crossref
Crossref
V. M. Fokina, M. Xu, E. Rytting, S. Z. Abdel-Rahman, H. West, C. Oncken, S. M. Clark, M. S. Ahmed, G. D. V. Hankins & T. N. Nanovskaya. (2016) Pharmacokinetics of Bupropion and Its Pharmacologically Active Metabolites in Pregnancy. Drug Metabolism and Disposition 44:11, pages 1832-1838.
Crossref
Crossref
R. L. Smith, T. Haslemo, H. Refsum & E. Molden. (2016) Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid—a large-scale study based on naturalistic therapeutic drug monitoring data. European Journal of Clinical Pharmacology 72:9, pages 1099-1104.
Crossref
Crossref
Nadia Kancheva LandoltTorsak BunupuradahPope KosalaraksaSasiwimol UbolyamNarukjaporn ThammajarukSerge CremersRoseann ZottStephen KerrJintanat Ananworanich. (2016) High Variability of Hormonal Levels and No Clinically Relevant Interaction Between Ethinyl Estradiol, Desogestrel and Lopinavir/Ritonavir in a Small Sample of HIV-positive Adolescents. JAIDS Journal of Acquired Immune Deficiency Syndromes 72:5, pages 507-512.
Crossref
Crossref
Jane E. Rogers, Arvind Dasari & Cathy Eng. (2016) The Treatment of Colorectal Cancer During Pregnancy: Cytotoxic Chemotherapy and Targeted Therapy Challenges. The Oncologist 21:5, pages 563-570.
Crossref
Crossref
Manthena V. Varma, Stefanus J. Steyn, Charlotte Allerton & Ayman F. El-Kattan. (2015) Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS). Pharmaceutical Research 32:12, pages 3785-3802.
Crossref
Crossref
Maren I. Blonk, Angela P. H. Colbers, Carmen Hidalgo-Tenorio, Kabamba Kabeya, Katharina Weizsäcker, Annette E. Haberl, José Moltó, David A. Hawkins, Marchina E. van der Ende, Andrea Gingelmaier, Graham P. Taylor, Jelena Ivanovic, Carlo Giaquinto & David M. Burger. (2015) Raltegravir in HIV-1–Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy. Clinical Infectious Diseases 61:5, pages 809-816.
Crossref
Crossref
Katherine L. Wisner, Dorothy K. Y. Sit, Eydie L. Moses-Kolko, Kara E. Driscoll, Beth A. Prairie, Catherine S. Stika, Heather F. Eng, John L. Dills, James F. Luther & Stephen R. Wisniewski. (2015) Transdermal Estradiol Treatment for Postpartum Depression. Journal of Clinical Psychopharmacology 35:4, pages 389-395.
Crossref
Crossref
Karl Walter Bock. (2015) Roles of human UDP-glucuronosyltransferases in clearance and homeostasis of endogenous substrates, and functional implications. Biochemical Pharmacology 96:2, pages 77-82.
Crossref
Crossref
Chasity D. AndrewsYun Lan YuehWilliam R. SpreenLeslie St. BernardMar Boente-CarreraKristina RodriguezAgegnehu GettieKasi Russell-LodrigueJames BlanchardSusan FordHiroshi MohriCecilia Cheng-MayerZhi HongDavid D. HoMartin Markowitz. (2015) A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge. Science Translational Medicine 7:270.
Crossref
Crossref
Sara K. Quinney, Avinash S. Patil & David A. Flockhart. (2014) Is personalized medicine achievable in obstetrics?. Seminars in Perinatology 38:8, pages 534-540.
Crossref
Crossref
Yang Zhao, Mary F. Hebert & Raman Venkataramanan. (2014) Basic obstetric pharmacology. Seminars in Perinatology 38:8, pages 475-486.
Crossref
Crossref
Mahamad Yunnus A. Mahat, B.S. Thippeswamy, Farhin R. Khan, Ramya Edunuri, Saranya Nidhyanandan & Shilpee Chaudhary. (2014) Pregnancy influences the plasma pharmacokinetics but not the cerebrospinal fluid pharmacokinetics of raltegravir: A preclinical investigation. European Journal of Pharmaceutical Sciences 65, pages 38-44.
Crossref
Crossref
Dong Gui Hu, Anne Rogers & Peter I. Mackenzie. (2014) Epirubicin Upregulates UDP Glucuronosyltransferase 2B7 Expression in Liver Cancer Cells via the p53 Pathway. Molecular Pharmacology 85:6, pages 887-897.
Crossref
Crossref
Su Sien OngAsli N. GoktugAyesha EliasJing WuDarren Saunders & Taosheng Chen. (2014) Stability of the human pregnane X receptor is regulated by E3 ligase UBR5 and serine/threonine kinase DYRK2. Biochemical Journal 459:1, pages 193-203.
Crossref
Crossref
James H. Fischer, Gloria E. Sarto, Jennifer Hardman, Loraine Endres, Thomas M. Jenkins, Sarah J. Kilpatrick, Hyunyoung Jeong, Stacie Geller, Kelly Deyo, Patricia A. Fischer & Keith A. Rodvold. (2013) Influence of Gestational Age and Body Weight on the Pharmacokinetics of Labetalol in Pregnancy. Clinical Pharmacokinetics 53:4, pages 373-383.
Crossref
Crossref
Ryan W. Dellinger, Angela M. Gomez Garcia & Frank L. MeyskensJr.Jr.. (2014) Differences in the Glucuronidation of Resveratrol and Pterostilbene: Altered Enzyme Specificity and Potential Gender Differences. Drug Metabolism and Pharmacokinetics 29:2, pages 112-119.
Crossref
Crossref
María L. Ruiz, Aldo D. Mottino, Viviana A. Catania & Mary Vore. 2011. Comprehensive Physiology. Comprehensive Physiology
1721
1740
.
Sze Wa Chan, Miao Hu, Sara Shun Wah Ko, Catherine Wing Yan Tam, Benny Siu Pong Fok, Ophelia Qi Ping Yin, Moses Sing Sum Chow & Brian Tomlinson. (2012) CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects. European Journal of Clinical Pharmacology 69:4, pages 799-806.
Crossref
Crossref
Su-Young Choi, Kwi Hye Koh & Hyunyoung Jeong. (2013) Isoform-Specific Regulation of Cytochromes P450 Expression by Estradiol and Progesterone. Drug Metabolism and Disposition 41:2, pages 263-269.
Crossref
Crossref
Xia Wen, Ajay C. Donepudi, Paul E. Thomas, Angela L. Slitt, Roberta S. King & Lauren M. Aleksunes. (2013) Regulation of Hepatic Phase II Metabolism in Pregnant Mice. Journal of Pharmacology and Experimental Therapeutics 344:1, pages 244-252.
Crossref
Crossref
Michael W. Sinz. 2015. Tactics in Contemporary Drug Design. Tactics in Contemporary Drug Design
159
190
.
Alexander V. LyubimovShalu Jhajra, Saranjit Singh, Karsten A. Holm, Ali Said Faqi & Jasminder Sahi. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
29
.
Shujuan Chen, Mei‐Fei Yueh, Ronald M. Evans & Robert H. Tukey. (2012)
Pregnane‐x‐receptor controls hepatic glucuronidation during pregnancy and neonatal development in humanized
UGT1
mice
. Hepatology 56:2, pages 658-667.
Crossref
Crossref
Kwi Hye Koh, Steve Jurkovic, Kyunghee Yang, Su-Young Choi, Jin Woo Jung, Kwang Pyo Kim, Wei Zhang & Hyunyoung Jeong. (2012) Estradiol induces cytochrome P450 2B6 expression at high concentrations: Implication in estrogen-mediated gene regulation in pregnancy. Biochemical Pharmacology 84:1, pages 93-103.
Crossref
Crossref
Khaled Abduljalil, Penny Furness, Trevor N. Johnson, Amin Rostami-Hodjegan & Hora Soltani. (2012) Anatomical, Physiological and Metabolic Changes with Gestational Age during Normal Pregnancy. Clinical Pharmacokinetics 51:6, pages 365-396.
Crossref
Crossref
Su-Young Choi, Liam Fischer, Kyunghee Yang, Hyejin Chung & Hyunyoung Jeong. (2011) Isoform-specific regulation of cytochrome P450 expression and activity by estradiol in female rats. Biochemical Pharmacology 81:6, pages 777-782.
Crossref
Crossref
Marianne Garland. 2011. Fetal and Neonatal Physiology. Fetal and Neonatal Physiology
252
262
.
Teresa Maria J. P. Carvalho, Ricardo de Carvalho Cavalli, Sérgio P. Cunha, Cláudia O. de Baraldi, Maria P. Marques, Natalícia J. Antunes, Ana Leonor P. C. Godoy & Vera Lucia Lanchote. (2010) Influence of gestational diabetes mellitus on the stereoselective kinetic disposition and metabolism of labetalol in hypertensive patients. European Journal of Clinical Pharmacology 67:1, pages 55-61.
Crossref
Crossref
Stefanie D. Krämer & Bernard Testa. (2009) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 6:10, pages 1477-1660.
Crossref
Crossref
Huiqing Chen, Kyunghee Yang, Suyoung Choi, James H. Fischer & Hyunyoung Jeong. (2009) Up-Regulation of UDP-Glucuronosyltransferase (UGT) 1A4 by 17β-Estradiol: A Potential Mechanism of Increased Lamotrigine Elimination in Pregnancy. Drug Metabolism and Disposition 37:9, pages 1841-1847.
Crossref
Crossref
Misty R. Saracino, Jeannette Bigler, Yvonne Schwarz, Jyh-Lurn Chang, Shiuying Li, Lin Li, Emily White, John D. Potter & Johanna W. Lampe. (2009) Citrus Fruit Intake Is Associated with Lower Serum Bilirubin Concentration among Women with the UGT1A1*28 Polymorphism. The Journal of Nutrition 139:3, pages 555-560.
Crossref
Crossref
Gail D. Anderson & Darcy B. Carr. (2009) Effect of Pregnancy on the Pharmacokinetics of Antihypertensive Drugs. Clinical Pharmacokinetics 48:3, pages 159-168.
Crossref
Crossref